Hemogenyx Pharmaceuticals Plc

Hemogenyx Pharmaceuticals Plc - Enterprise Valueverified

HOPHF

Price:

$2.33

Market Cap:

$31.08M

Hemogenyx Pharmaceuticals Plc is a preclinical-stage biotechnology firm dedicated to discovering, developing, and bringing to market innovative therapies for various blood-related diseases. The company's pipeline includes several promising candidates tailored for the bone marrow/hematopoietic stem cell (BM/HSC) transplant market. These include a CDX bi-specific antibody designed to target relapsed/refractory acute myeloid leukemia (R/R AML), certain forms of acute lymphoblastic leukemia, and myelodysplastic syndrome. This novel approach seeks to condition patients for bone marrow transplants, offering a potential alternative to conventional chemotherapy and/or radiation treatments. Additiona...[Read more]

Industry

Biotechnology

IPO Date

2021-01-12

Stock Exchange

OTC

Ticker

HOPHF

The Enterprise Value as of September 2026 (TTM) for Hemogenyx Pharmaceuticals Plc (HOPHF) is 31.49M

According to Hemogenyx Pharmaceuticals Plc’s latest financial reports and current stock price. The company's current Enterprise Value is 31.49M. This represents a change of 66.01% compared to the average of 18.97M of the last 4 quarters.

Hemogenyx Pharmaceuticals Plc (HOPHF) Historical Enterprise Value (quarterly & annually)

How has HOPHF Enterprise Value performed in the past?

The mean historical Enterprise Value of Hemogenyx Pharmaceuticals Plc over the last ten years is 15.87M. The current 31.49M Enterprise Value has changed 19.74% with respect to the historical average. Over the past ten years (40 quarters), HOPHF's Enterprise Value was at its highest in in the December 2020 quarter at 41.66M. The Enterprise Value was at its lowest in in the August 2014 quarter at 0.

Quarterly (TTM)
Annual

Average

15.87M

Median

11.24M

Minimum

4.63M

Maximum

39.85M

Hemogenyx Pharmaceuticals Plc (HOPHF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Hemogenyx Pharmaceuticals Plc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 411.35%

Maximum Annual Enterprise Value = 39.85M

Minimum Annual Increase = -80.72%

Minimum Annual Enterprise Value = 4.63M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202525.83M63.12%
202415.83M-42.77%
202327.67M99.46%
202213.87M80.60%
20217.68M-80.72%
202039.85M411.35%
20197.79M11.75%
20186.97M50.60%
20174.63M-46.17%
20168.60M352.42%

Hemogenyx Pharmaceuticals Plc (HOPHF) Average Enterprise Value

How has HOPHF Enterprise Value performed in the past?

The current Enterprise Value of Hemogenyx Pharmaceuticals Plc (HOPHF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

23.11M

5-year avg

18.18M

10-year avg

15.87M

Hemogenyx Pharmaceuticals Plc (HOPHF) Enterprise Value vs. Peers

How is HOPHF’s Enterprise Value compared to its peers?

Hemogenyx Pharmaceuticals Plc’s Enterprise Value is greater than Comera Life Sciences Holdings, Inc. (331.51K), greater than Cadrenal Therapeutics, Inc. Common Stock (1.61M), less than Fennec Pharmaceuticals Inc. (333.22M), less than Foghorn Therapeutics Inc. (221.62M), greater than Algorae Pharmaceuticals Limited (15.06M), less than Resverlogix Corp. (99.64M),

Build a custom stock screener for Hemogenyx Pharmaceuticals Plc (HOPHF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hemogenyx Pharmaceuticals Plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Hemogenyx Pharmaceuticals Plc (HOPHF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Hemogenyx Pharmaceuticals Plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Hemogenyx Pharmaceuticals Plc's Enterprise Value?

What is the highest Enterprise Value for Hemogenyx Pharmaceuticals Plc (HOPHF)?

What is the 3-year average Enterprise Value for Hemogenyx Pharmaceuticals Plc (HOPHF)?

What is the 5-year average Enterprise Value for Hemogenyx Pharmaceuticals Plc (HOPHF)?

How does the current Enterprise Value for Hemogenyx Pharmaceuticals Plc (HOPHF) compare to its historical average?